TMFGBudwell

George Budwell

TMFGBudwell’s Activity

Yesterday

NL

Article

gbudwell published an article 10:33 AM

Why Exelixis, Inc. Stock Is Soaring Today

Shares of small-cap biopharma Exelixis Inc. are up big today. Here's why.

Fri Sep 26

NL

Article

gbudwell published an article 6:20 AM

The Next Industry Google Plans to Transform

Google is leveraging its vast resources to create high-impact technologies that could transform modern medicine. Here is what you need to know.

Wed Sep 24

NL

Article

gbudwell published an article 9:42 PM

What This Huge George Soros Mistake Can Teach You

George Soros is an investing genius. Still, he does make the occasional mistake. Here is a look at recent mistake with Gilead Sciences Inc. that cost the billionaire serious gains.

NL

Article

gbudwell published an article 10:02 AM

Why Merrimack Pharmaceuticals Inc Stock Is Soaring Today

Merrimack shares are up over 12% today. Here's why.

NL

Article

gbudwell published an article 9:01 AM

Should Pfizer Inc. Buy Actavis plc?

Pfizer is in a bit of pickle when it comes to generating growth. Although the company is flush with cash, it doesn't have much in the way of major new drugs in the pipeline and has a mountain of cash locked up abroad. Here is one way Pfizer could [more]

NL

Article

gbudwell published an article 3:52 AM

Is It Time to Buy Dividend Stock Teva Pharmaceutical Industries Ltd?

Teva Pharmaceutical shares have buckled under the pressure of generic Copaxone launches. Is the stock now attractively priced?

Mon Sep 22

NL

Article

gbudwell published an article 9:47 AM

Why Sigma-Aldrich Corporation Stock Is Soaring Today

Shares of St. Louis-based Sigma-Aldrich Corporation are soaring higher today. Here's why.

Sun Sep 21

NL

Article

gbudwell published an article 10:43 PM

GlaxoSmithKline Keeps Setting Records, but Not in a Good Way

GlaxoSmithKline plc's Chinese bribery scandal concluded last week, resulting in yet another record fine for the company. With this case finally resolved, could shares start to rebound?

Fri Sep 19

NL

Article

gbudwell published an article 1:46 AM

Dividend Aristocrats: Time to Buy AbbVie Inc Stock?

AbbVie is an innovative pharma company with an attractive yield and a strong outlook for top-line growth going forward. Here's why investors should dig into this top dividend stock.

Thu Sep 18

NL

Article

gbudwell published an article 1:12 AM

Is It Time to Buy Dividend Stock Bristol-Myers Squibb Co?

Bristol-Myers Squibb's share price has lagged behind its peers in recent months. Could this weakness present a compelling buying opportunity?

Wed Sep 17

NL

Article

gbudwell published an article 9:44 AM

Why Auxilium Pharmaceuticals Inc. Stock Is Skyrocketing Today

Auxilium Pharmaceuticals stock is soaring today. Here's why.

Tue Sep 16

NL

Article

gbudwell published an article 1:30 AM

Is It Time to Buy GlaxoSmithKline plc Stock?

GlaxoSmithKline's stock has had a rough year due to falling revenues. Can the stock rebound?

Mon Sep 15

NL

Article

gbudwell published an article 12:13 AM

3 Reasons Actavis plc Stock Could Fall

Shares of specialty drugmaker Actavis have been ripping higher over the past two years. Here are three reasons why this trend could be coming to an end.

Sun Sep 14

NL

Article

gbudwell published an article 11:48 PM

3 Reasons Dividend Stock Teva Pharmaceutical Industries Ltd. Could Fall

Teva Pharmaceutical Industries has been on a nice bull run for the past year. Here are three reasons why this trend might be about to reverse.

Fri Sep 12

NL

Article

gbudwell published an article 10:09 AM

Why Amarin Corporation plc Stock Cratered

Amarin's stock is plunging today. Here's why.

NL

Article

gbudwell published an article 7:02 AM

2 New Diet Drugs Coming Soon?

Orexigen Therapeutics and Novo Nordisk are close to bringing new diet drugs to market. But will doctors prescribe them?

Thu Sep 11

NL

Article

gbudwell published an article 11:53 PM

George Soros Is Betting on This Risky Stock: Should You?

Sarepta Therapeutics is a clinical-stage biotechnology company seeking to gain approval for a potentially game-changing Duchenne muscular dystrophy drug called eteplirsen. Wall Street appears convinced that the drug is a winner, but scientists have [more]

Wed Sep 10

NL

Article

gbudwell published an article 12:39 AM

Why I'd Avoid Pfizer Inc. Stock Despite the Dividend

Dividend stocks are an important part of a well-rounded portfolio. Yet some high-yielding stocks are better left alone. Here is a look at one top name in healthcare that investors should avoid for the time being.

Sat Sep 6

NL

Article

gbudwell published an article 11:44 PM

A Top Dividend Stock for Your Portfolio: Johnson & Johnson

This healthcare stock offers investors an attractive dividend yield, a strong balance sheet, and a long history of market-beating returns.

Fri Sep 5

NL

Article

gbudwell published an article 11:53 PM

Is It Time to Buy Actavis plc Stock?

Shares of specialty drugmaker Actavis have been hitting all-time highs lately. With an acquisition-fueled revenue bonanza taking place, is it time to buy shares of this red-hot biopharma?

Show More Activity ...

CAPS Stats & Trivia

CAPS Player Rating < 20
Player Rank 0 out of 75037
Score 0.00
Score Change Today 0
Accuracy 0.00%
Active Picks 0
Total Picks 5
Best Pick GILD (+7.59)
Worst Pick IMUC (-28.72)
Average Score per Pick 0.00
Charms Earned 0
Highest Rated Favorite No Favorites Selected
Go to TMFGBudwell’s CAPS page

Boards Stats & Trivia

Board Posts 0
Recs Received 0
People who have rec'd these posts 0
Recs to Posts Ratio (last 30 days) N/A
Threads Started 0
Threads Started Percentage 0.00 %
Most Frequent Board N/A
Very First Post N/A
Percentage of Posts Rec'd 100.00 %
Show TMFGBudwell’s 10 Latest Posts